Gojo, Javelle B.

HRN: 28-18-59  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/30/2025
GENTAMICIN 40MG/ML, 2ML (AMP)
11/30/2025
12/07/2025
IV
12mg
Q24HRS
Sepsis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: Compliant To Guidelines